nitazoxanide has been researched along with niclosamide in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Allman, SA; Bentley, J; Berry, NG; Edwards, G; Hellier, J; Helm, A; Iqbal, M; Korba, BE; Pidathala, C; Rossignol, JF; Row, EC; Semple, JE; Sharma, R; Stachulski, AV | 1 |
| Allman, SA; Bentley, J; Berry, NG; Edwards, G; Hellier, J; Helm, A; Iqbal, M; Korba, BE; Lawrenson, AS; Moores, SL; Pidathala, C; Rossignol, JF; Row, EC; Semple, JE; Sharma, R; Stachulski, AV | 1 |
| Aquino, TM; Araújo-Júnior, JX; da Silva-Júnior, EF; Leoncini, GO; Rodrigues, ÉES | 1 |
| Akiyoshi, S; Hirose, L; Iwata, M; Kohara, H; Liao, J; Sawada, R; Tani, K; Yamanishi, Y | 1 |
| Gao, J; Guo, Y; Hu, X; Huang, H; Jin, Z; Li, Z; Liu, Z; Wang, K; Wang, Y; Zhang, L; Zhong, Y; Zong, X | 1 |
| Constant, P; Daffé, M; Guillet, V; Le, NH; Marrakchi, H; Maveyraud, L; Mourey, L; Nahoum, V; Tranier, S; Verhaeghe, P | 1 |
| Chin, YF; Ho, YJ; Kuo, SC; Lai, ZZ; Lin, CC; Lin, LI; Lu, JW; Wang, YM; Wu, TY | 1 |
| Brehm, K; Hemphill, A; Kaempfer, T; Kaethner, M; Lundström-Stadelmann, B; Preza, M; Tamponi, C; Varcasia, A; Zumstein, P | 1 |
1 review(s) available for nitazoxanide and niclosamide
| Article | Year |
|---|---|
The medicinal chemistry of Chikungunya virus.
Topics: Animals; Antiviral Agents; Biological Products; Chemistry, Pharmaceutical; Chikungunya Fever; Chikungunya virus; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
7 other study(ies) available for nitazoxanide and niclosamide
| Article | Year |
|---|---|
Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication.
Topics: Amides; Animals; Antiviral Agents; Dogs; Glucuronides; Hep G2 Cells; Hepatitis B virus; Humans; In Vitro Techniques; Prodrugs; Quantitative Structure-Activity Relationship; Rats; Salicylamides; Thiazoles; Virion; Virus Replication | 2011 |
Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication.
Topics: Amides; Antiviral Agents; Cell Line; Hepacivirus; Humans; Quantitative Structure-Activity Relationship; Thiazoles; Virus Replication | 2011 |
Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation.
Topics: Antineoplastic Agents; Computational Biology; Drug Repositioning; Neoplasms | 2018 |
Optimization of 4-arylthiophene-3-carboxylic acid derivatives as inhibitors of ANO1: Lead optimization studies toward their analgesic efficacy for inflammatory pain.
Topics: Analgesics; Animals; Anoctamin-1; Carboxylic Acids; HEK293 Cells; Humans; Hyperalgesia; Mice; Neoplasm Proteins; Pain | 2022 |
Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis.
Topics: Adenosine Monophosphate; Antitubercular Agents; Drug Evaluation, Preclinical; Humans; Mycobacterium tuberculosis; Salicylanilides; Tuberculosis | 2022 |
Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
Topics: Animals; Antiviral Agents; Cell Line; Chikungunya Fever; Chikungunya virus; Drug Discovery; High-Throughput Screening Assays; Humans; Niclosamide; Nitro Compounds; Semliki forest virus; Sindbis Virus; Thiazoles; Virus Internalization; Virus Replication | 2016 |
Establishment and application of unbiased in vitro drug screening assays for the identification of compounds against Echinococcus granulosus sensu stricto.
Topics: Albendazole; Animals; Drug Evaluation, Preclinical; Echinococcus granulosus; Echinococcus multilocularis; Niclosamide | 2023 |